Development of a CMS Classifier for Clinical CRC Samples
bioRxiv (Cold Spring Harbor Laboratory)(2023)
摘要
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, emphasizing the need for improved predictive biomarkers to guide treatment decisions. A classification system based on gene expression profiles, known as CMS, has shown promise in stratifying CRC into distinct subtypes with varying clinical outcomes. However, the lack of a reliable assay to classify formalin-fixed paraffin-embedded (FFPE) samples poses a challenge for translating this system into routine clinical practice. In this paper, we introduce the NanoClassifier, an NanoString-based CMS classifier to classify both FFPE and Fresh frozen (FF) tumors. We demonstrate the strong accuracy of the NanoClassifier in predicting CMS for CRC samples. By validating its performance on FF and FFPE samples, we highlight the prognostic significance of CMS in CRC.
### Competing Interest Statement
The authors have declared no competing interest.
更多查看译文
关键词
cms classifier,clinical,samples
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要